Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生物資源暨農學院
  3. 動物科學技術學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9528
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor徐濟泰(Jih-Tay Hsu)
dc.contributor.authorPeng-Cheng Sunen
dc.contributor.author孫鵬乘zh_TW
dc.date.accessioned2021-05-20T20:27:02Z-
dc.date.available2010-09-02
dc.date.available2021-05-20T20:27:02Z-
dc.date.copyright2008-09-02
dc.date.issued2008
dc.date.submitted2008-08-20
dc.identifier.citation行政院衛生署,1999。健康食品安全及功效評估方法-健康食品調整腸胃功能評估方法。
行政院衛生署。2001。市售包裝食品營養宣稱規範。
行政院衛生署。2004。中華民國93年國民醫療保健支出統計。
行政院衛生署。2005。中華民國94年全民健康保險醫療統計年報。
吳輔祐 and Elsasser, T. H.。1995。羊乳促進細胞生長活性之研究。中國農業化學會誌 33: 326-332。
曹博宏、吳輔祐、徐濟泰。2002。影響羊乳血小板活化因子乙醯水解酵素(PAF-AH)活性之研究。中畜會誌31: 215。
壽廉。1979。人體免疫球蛋白。中華醫誌 26:1-11。
Aronson, M. 1952. Transgalactosidation during lactose hydrolysis. Arch Biochem Biophys 39:370-378.
Bartram, H. P., W. Scheppach, H. Schmid, A. Hofmann, G. Dusel, F. Richter, A. Richter, and H. Kasper. 1993. Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia, and pH. Cancer Res. 53: 3283-3288.
Beerens, H., C. Romond and C. Neut. 1980. Influence of breast-feeding on the bifid flora of newborn intestine. Am. J. Clin. Nutr. 33:2434-2439.
Boehm, G., and B. Stahl. 2003. Oligosaccharides. In T. Mattila and M.Saarela Eds., Functional Dairy Products. pp. 203-243. Cambridge, England: Woodhead Publishing Limited.
Bouhnik, Y., B. Flourie, L, D’Agay-Abensour, P. Pochart, G. Gramet, M. Durand and J. C. Rambaud. 1997. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J. Nutr. 127:444-448.
Brandt, L.A. 2001. Prebiotics enhance gut health. Prepared Foods. 170: 7-10.
Britigan, B.E., J.S. Serody and M.S. Cohen. 1994. The role of lactoferrin as an anti-inflammatory molecule. Adv. Exp. Med. Biol. 357: 143-156.
Brock, J. 1995. Lactoferrin: a multifunctional immunoregulatory protein? Immunol. Today 16: 417-419.
Brown, K. D. and D. M. Blakeley. 1983. Cell growth-promoting activity in mammary secretions of the goat, cow and sheep. Br Vet J. 139: 68-78.
Carpenter, G. 1980. Epidermal growth factor is a major growth-promoting agent in human milk. Science 210: 198-199.
Chantal, M., C. V. Juan, M. Marcela, R. Mirtha and P. Gabriela. 2001. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. of Dairy Res. 68: 601-609.
Chonan, O., K. Matsumoto and M. Watanuki. 1995. Effect of galacto-oligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci. Biotech. Biochem. 59:236-239.
Collins, M. D. and G. R. Gibson. 1999. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69: 1052-1057.
Conway, P. L. 2001. Prebiotics and human health: the state-of-the-art and future perspectives. Scand. J. Nutr. 45:13-21.
Crittenden, R.G., and M. J. Playne. 1996. Production, properties and applications of food-grade oligosaccharides. Trends Food Sci. Technol. 7(11):353-361.
Crouch, S.P.M., K.J. Slater and J. Fletcher. 1992. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80: 235-240.
Cummings, J.H., M. B. Roberfroid, H. Anderson, C. Barth, A. Ferro-Luzzi, Y. Ghoos, M. Gibney, K. Hermonsen, W. P. T. James, O. Korver, D. Lairon, G. Pascal and A. G. S. Voragen. 1997. A new look at dietary carbohydrate: Chemistry, physiology and health. Eur. J. Clin. Nutr. 51:417-423.
Daddaoua, A., V. Puerta, P. Requena, A. Martínez-Férez, E. Guadix, F. S. de Medina, A. Zarzuelo, M. D. Suárez, J. J. Boza. and O. Martínez-Augustin. 2006. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J. Ntur. 136: 672-676.
Fanaro, S., G. Boehm, J. Garssen, J. Knol, F. Mosca, B. Stahl and V. Vigi. 2005. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: A review. Acta Paediatrica 94:22-26.
Fooks, L. J. and G. R. Gibson. 2002. Probiotics as modulators of the gut flora. Br. J. Nutr. 88: 39-49.
Fooks, L. J., R. Fuller and G. R. Gibson. 1999. Prebiotics, probiotics and human gut microbiology. Int. Dairy J. 9: 53-61.
Forestier, C., C. D. Champs, C. Vatoux and B. Joly. 2001. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol. 152: 167-173.
Furrie, E., S. Macfarlane, A. Kennedy, J. H. Cummings, S. V. Walsh, D. A. O'neil and G.. T. Macfarlane. 2005. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 54: 242-249.
Gibson, G. R. and A. L. McCartney. 1998. Modification of the gut flora by dietary means. Biochem. Soc. T. 26: 222-228.
Ginsberg, D. I., C. Drapeau and G. S. Jensen. 2000. Probiotic bacteria and the immune system. JANA. 3: 44-50.
Goldin, B. R. 1998. Health benefits of probiotics. Br. J. Nutr. 80(2): 203-207.
Gopal, P. K. and H. S. Gill. 2000. Oligosaccharides and glycoconjugates in bovine milk and colostrum. Bri. J. Nutr. 84(Sup. 1): S69-74.
Gorbach, S. L. 1990. Lactic acid bacteria and human health. Ann. Med. 22: 37-41.
Grieshop, C. M., E. A. Flikinger, K. J. Bruce, A. R. Patil, G. L. Czarnecki-Maulden and G. C. Fahey, Jr. 2004. Gastrointestinal and immunological responses of senior dogs to chicory and mannan-oligosaccharides. Arch. Anim. Nutr. 58: 483-493
Guidos, C., A.A. Sinha and K.C. Lee. 1987. Functional differences and complementation between dendritic cells and macrophages in T-cell activation. Immunol. 61: 269-276.
Guigoz, Y., F. Rochat, G. Perruisseau-Carrier, I. Rochat and E. J. Schiffrin. 2002. Effect of oligosaccharide on the faecal flora and nonspecific immune system in elderly people. Nut. Res. 22: 13-25.
Hansen, M. B., S. E. Nielson and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119: 302-310.
Harris, P. J. and L. R. Ferguson. 1999. Dietary fibers may protect or enhance carcinogenesis. Mutat. Res. Gen. Toxicol. Environ. 443: 95-110.
Hasen, R. 1985. Bifidobacteria have come to Denmark to stay. N. Eur. Dairy. J. 51: 79-83.
Hoijer, M. A., M. J. Melief, C. G. Helden-Meeuwsen, F. Eulderink and M. P. Hazenberg. 1995. Detection of muramic acid in a carbohydrate fraction of human spleen. Infect. & Immun. 63(5): 1652-1657.
Holzapfel, W. H., P. Haberer, J. Snel, U. Schillinger and J. H. Huis In’t Veld. 1998. Overview of gut flora and probiotics. Inter. J. Food Micro. 41: 85-101.
Imaizumi, T., D. M. Stafforini, Y. Yamada, T. M. Mcintyre, S. M. Prescott and G. A. Zimmerman. 1995. Platelet-activating factor: a mediator for clinicians. J. Intern Med. 238: 5-20.
Ishikawa, F., H. Takayama, K. Matsumoto, M. Ito, O. Chonan, Y. Deguchi, H. Kikuchi-Hayakawa and M. Watanuki. 1995. Effects of β1-4 linked galacto-oligosaccharides on human fecal microflora. Bifidus. 9:5-18.
Isolauri, E., P. V. Kirjavainen and S. Salminen. 2002. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 50(Suppl ): 54-59.
Ito, M., K. Matsumoto, M. Kimura, N. Onodera and T. Yajima. 1993. Influence of galactooligosaccharides on the human fecal microflora. J. Nutr. Sci. Vitaminol 39: 635-640.
Ito, M., Y. Deguchi, A. Miyamori, K. Matsumoto, H. Kimkuchi, K. Matsumoto, Y. Kobayashi, T. Yajima and T. Kan. 1990. Effects of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation. Microb. Ecol. Health Dis. 3:285-292.
Jenkins, D. J. A., C. W. C. Kendall and V. Vuksan. 1999. Inulin, oligofructose and intestinal function. J. Nutr. 129:1431S-1433S (Suppl. S).
Johnson, I. T. 2004. New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutation Res. 551:9-28.
Kasper, H. 1998. Protection against gastrointestional diseases- present facts and future developments. Inter. J. Food Micro. 41: 127-31.
Kaur, N. and A. Gupta. 2002. Applications of inulin and oligofructose in health and nutrition. J. Biosci. 27(7):703-714.
Kawakami, K., I. Makino, T. Asahara, I. Kato and M. Onoue. 2005. Dietary galacto-oligosaccharides mixture can suppress serum phenol and p-cresol levels in rats fed tyrosine diet. J. Nutr. Sci. Vitaminol. 51:182-186.
Kawase, K., T. Suzuki, I. Kiyosawa, S. Okonogi, T. Kawashima and M. Kuboyama. 1981. Effects of composition of infant’s formulas on the intestinal microflora of infants. Bifidobacteria Microflora 2: 25-31.
Kelly-Quagliana, K. A., P. D. Nelson and R. K. Buddington. 2003. Dietary oligofructose and inulin modulate immune functions in mice. Nut. Res. 23: 257-267.
Kikuchi, H. H., M. Kimura and M. Watanuki. 1997. Adaptation of rate of organic acid production of hindgut bacteria to chronic intake of galactooligosaccharide in the rat. J. Nutr. Sci. Vitaminol. 43:357-68.
Kirsch, C.M., J. J. Brokaw, D. M. Prow and G. W. White. 1992. Mechanism of platelet-activating factor -induced vascular leakage in the rat trachea. Exp. Lung Res. 18:447-459.
Kuby, J. 1994. Immunology. 2nd ed. W. H. Freeman Co., New York.
Kunz, C., and S. Rudloff. 2002. Health benefits of milk-derived carbohydrates. Bulletin of the International Dairy Federation. 375: 72-79.
Lilly, D. M. and R. H. Stillwell. 1965. Probiotics: growth promoting factors produced by microorganisms. Science 147: 747-748.
Macfarlane, G. T. and J. H. Cummings. 1999. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? Br. Med. J. 318: 999-1003
Mack, D. R., S. Michail, S. Wei, L. Mcdougall and M. A. Hollingsworth. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276: G941-G950.
Manning, T. S. and G. R. Gibson. 2004. Prebiotics. Best Practice Res. Clin. Gastroenterol. 18(2):287-298.
Matsumoto, K. 1990. Characterization and utilization of β-galactosidase from lactic acid bacteria and bifidobactera. Jap. J. Dairy Food Sci. 39: 239-248.
McIntyre, A., P. R. Gibson and G. P. Young. 1993. Butyrate production from dietary fiber and protection against large bowel cancer in a rat model. Gut. 34: 386-391.
Mehra, R. and P. Kelly. 2006. Milk oligosaccharides : Structural and technological aspects. International Dairy Journal. 16: 1334-1340.
Middelbos, I. S., M. R. Godoy, N. D. Fastinger and G. C. Fahey, Jr. 2007a. A dose-response evaluation of spray-dried yeast cell wall supplementation of diets fed to adult dogs: Effects on nutrient digestibility, immune indices, and fecal microbial populations. J. Anim. Sci. 85: 3022-3032.
Middelbos, I. S., N. D. Fastinger and G. C. Fahey, Jr. 2007b. Evaluation of fermentable oligosaccharids in diets fed to dogs in comparison to fiber standard. J. Anim. Sci. 85: 3033-3044.
Minekawa, R., T. Takeda, M. Sakata, M. Hayashi,A. Isobe, T. Yamamoto, K. Tasaka and Y. Murata. 2004. Human breast milk suppresses the transcriptional regulation of IL-1beta-induced NF-kappaB signaling in human intestinal cells. Am. J. Physiol. Cell Physiol. 287:1404-1411.
Mitsuoka, T. 1982. Recent trends in research on intestinal flora. Bifidobact. Microflora. 1: 3-24.
Moore, S.A., B.F. Anderson, C.R. Groom, M. Haridas and E.N. Baker. 1997. Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution. J. Mol. Biol. 274: 222-236.
Mozaffar, Z., K. Nakanishi, R. Matsuno and T. Kamikuro. 1984. Purification and properties of β-galactosidase from Bacillus circulans. Agric. Bio. Chem. 48: 3053-3061.
Nakamura, T. and T. Urashima. 2004. The milk oligosaccharides of domestic farm animals. Trends in Glycoscience and Glycotechnology. 16: 135-142.
Narimiya, M., K. Yokoi, N. Tajima, O. Sakai, Y. Ikeda and H. Takayama. 1996. The effect of β1-4 galactooligosaccharides on fecal flora in non insulin dependent diabetic patients with constipation. Jap. J. Clin. Nutr. 18:44-50.
Newburg, D. S. 1996. Oligosaccharides and glycoconjugates in human milk: their role in host defense. J. Mammary Gland Biol. Neoplasia. 1: 271-83.
Nichols, B.L., K.S. McKee, J.F. Henry and M. Putman, 1987. Human lactoferrin stimulates thymidine incorporation into DNA of rat crypt cells. Pediatr. Res. 21: 563-567.
Ohtsuka, K., K. Tsuji, Y. Nakagawa, H. Ueda, O. Ozawa, T. Uchida and T. Mitsuoka. 1989. Effects of 4’-galactosyllactose (O-beta-D-galactopyranosyl-(1-4)-O-beta- D-galactopyranosyl-(1-4)-D-glucopyranose) in rat. J Nutr. Sci. Vitaminol 36: 265-276.
Ohtsuka, K., A. Tanoh, O. Ozawa, T. Kanematsu, T. Uchida and R. Shinke. 1990. Purification and properties of a β-galactosidase with high galactosyl transfer activity from Cryptococcus laurentii. J. Ferment Bioeng. 70:301-307.
Okazaki, M., S. Fujikawa and N. Matsumoto. 1990. Effect of xylooligosaccharide on the growth of Bifidobacteria. Bifidobact. Microflora. 9: 77-86.
Ozawa, O., K. Ohtsuka and R. Uchida. 1989. Production of 4’-galactosyllactose by mixed cells of Cryptococcus laurentii and baker’s yeast. Nippon Shokuhin Kogyo Gakkaishi. 36:898-902.
Perdigon, G.., S. Alvarez, M. Rachid, G. Aguero and N. Gobbato. 1995. Immune system stimulation by probiotics. J. Dairy Sci. 78: 1597-1606.
Prenosil, J.E., E. Stuker, J. R. Bourne. 1987. Formation of oligosaccharides during enzymatic lactose: Part I: State of art. Biotechnol Bioeng 30:1019-1025.
Prescott, S.M., G. A. Zimmermann and T. M. McIntyre. 1990. Platelet-activating factor. J. Biol. Chem. 265: 17381-17384.
Quan, S. and S. G. Harsharnjit. 2002. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20TM) against Escherichia coli O157:H7 infection in mice. FEMS Immunol. Medical Microbio. 34: 59-64.
Rasic, J. L. and J. A. Kurmann. 1983. Bifidobacteria and their role. Microbiological, nutritional-physiological, medical and technological aspects and bibliography. Experientia. Suppl. 39: 1-295.
Roberfroid, M.B. 1997. Health benefits of non-digestible oligosaccharides. In: Kritchevsky and Bonfield. Dietary fiber in health and disease. New York, Plenum Press. pp: 211-219.
Roberfroid, M.B. 2000. Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr. 71:1682S-1687S (Suppl. S).
Roberfroid, M.B., G. R. Gibson and N. Delzenne. 1993. Biochemistry of oilgofructose, a non-digestible fructo-oligosaccharide: An approach to estimate its caloric value Nutr. Rev. 51:137-146.
Roitt, I. 1984. Essential Immunology. 5th ed. Blackwell Scientific Publications. Oxford.
Roitt, I., J. Brostoff and D. Male. 1993. Immunology, 3rd ed. Mosby-Year Book Europe, lnc., England.
Rolfe, R. D. 2000. The role of probiotic cultures in the control of gastrointestinal health. J. Nutr. 130: 396s-402s.
Rowland, I. 1988. Interactions of the gut microflora and the host in toxicology. Toxicol Pathol. 16:147-153.
Rowland, I. and R. Tanaka. 1993. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human fecal microflora. J. Appl. Bacteriol. 74:667-674.
Sako, T., K. Matsumoto and R. Tanaka. 1999. Recent progress on research and applications of non-digestible galacto-oligosaccharides. Int. Dairy J. 9: 69-80
Sanders, M. E., D. C. Walker, K. M. Walker, K. Aoyama and T. R. Klaenhammer. 1996 Performance of commercial cultures in fluid milk applications. J. Dairy Sci. 79: 943-55.
Schrezenmeir, J. and M. Vrese. 2001. Pobiotics, prebiotics, and synbiotics-approaching a definition. Am. J. Clin Nutr. 73: 361-364.
Shishikura, T., K. Shito, M. Uchida and T. Inaba. 2006. A late cutaneous response in actively sensitized rats: a new method for evaluating the efficacy of antiallergic drugs. J. Pharmacol Sci. 101: 350-355.
Shimoyama, T., S. Hori, S. Tamura, M. Yamamura, M. Tanaka and K. Yamazaki. 1984 Microflora of patients with stool abnormality. Bifidobacteria Microflora 3:35-42.
Silva, M., N. V. Jacobus, C. Deneke, and S. L. Gorbach. 1987. Antimicrobial substance from a human Lactobacillus stain. Antimicrob. Agents Chemother. 31: 1231-1233.
So, Y. P., E. J. Geun, T. K. Young, K. J. Hoo and U. Zeynep. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. of Food Microbiol. 46: 231-241.
Stark, P. L. and A. Lee. 1982. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J. Med. Microbiol. 15:189-203.
Steijns, J. M. and A.C.M. Hooijdonk. 2000. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. Br. J. Nutr. 1: 11-17.
Stephen, P. J. and E. Maetin. 1994. Human gastrointestinal mucosal T cells. In: Handbook of Mucosal Immunology. pp: 275-285. Academic Press, London.
Swanson, K. S., C. M. Grieshop, E. A. Flickinger, L. L. Bauer, H. P. Healy, K. A. Dawson, N. R. Merchen and G. C. Fahey, Jr. 2002a. Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dog. J. Nutr. 132: 980-989.
Swanson, K. S., C. M. Grieshop, E. A. Flickinger, H. P. Healy, K. A. Dawson, N. R. Merchen and G. C. Fahey, Jr. 2002b. Effects of supplemental fructooligosaccharides plus mannanoligosaccharides on immune function and ileal and fecal microbial populations in adult dogs. Arch. Anim. Nutr. 56: 309-318.
Swennen, K., C. M. Courtin and J. A. Delcour. 2006. Non-digestible oligosaccharides with prebiotic properties. Food Sci. Nutr. 46: 459-471.
Tamai, S., K. Ohtsuka, O. Ozawa and T. Uchida. 1992. Effect of a small amount of galactooligosaccharides on fecal Bifidobacterium. J. Jap. Soc. Nutr. Food Sci. 45:456-460.
Tanaka, R., H. Takayama, M. Morotomi, T. Kuroshima, S. Ueyama, K. Matsumoto, A. Kuroda and M. Mutai. 1983. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobacteria Microflora. 2:17-24.
Tannock, G. W. 1997. Probiotic properties of lactic acid bacteria: plenty of scope for fundamental R and D. Tibtech. 6: 270-274.
Teitelbaum, J.E., and W. A. Walker. 2002. Nutritional impact of pre-and probiotics as protective gastrointestinal organisms. Annu. Rev. Nutr. 22:107-138.
Teuri, U. and R. Korpela. 1998. Galacto-oligosaccharides relieve constipation in elderly people. Ann. Nutr. Metab. 42: 319-327.
Teuri, U., R. Korpela, M. Saxelin, L. Montonen and S. Salminen. 1998. Increased fecal frenquency and gastrointestinal symptoms following ingestion of galacto-oligosaccharide-containing yogurt. J. Nutr. Sci. Vitaminol 44:465-471.
Tochikura, T., K. Sakai, T. Fujiyoshi, T. Tachiki and H. Kumagai. 1986. p-Nitrophenyl glucoside-hydrolyzing activities in bifidobacteria and characterization of β-d-galactosidase of Bifidobacterium longum. Agric. Biol. Chem. 50:2279-2286.
Tsai, G. J. and S. C. Yu. 1997. An enzyme-linked immunosorbent assay for the detection of Aspergillus parasiticus and Aspergillus flavus. J. Food Prot. 60: 978-984.
Umetsu, D.T., O. Akbari and R.H. Dekruyff. 2003. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol. 112: 480-487.
van Dokkum, W., B. Wezendonk, T. S. Srikumar and E. G. H. M. van den Heuvel. 1999. Effect of non digestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur. J. Clin. Nutr. 53:1-7.
Velazquez, O. C., H. M. Lederer and J. L. Rombeau. 1996. Butyrate and the colonocyte. Implications for neoplasia. Dig. Dis. Sci. 41: 729-739.
Vince, A. and S. M. Burridge. 1980. Ammonia production by intestinal bacteria: The effects of lactose, lactulose and glucose. J. Med. Microbiol. 13:177-191.
Voragen, A. G. J. 1998. Technological aspects of functional food-related carbohydrates. Trends Food Sci. Technol. 9:328-335.
Vrese, M., A. Stegelmann, B. Richter, S. Fenselau, C. Lauem and J. Schrezenmeir. 2001. Probiotics- compensation for lactase insufficiency. Am. J. Clin Nutr. 73: 421-429.
Watanuki, M., Y. Wada and K. Matsumoto. 1996. Digestibility and physiological heat of combustions of β1-4 and β1-6 galacto-oligosaccharides in vitro. Annu. Rep. Yakult Central Institute Microbiol Res. 16:1-12.
Welsh, J. K. and J. T. May. 1979. Anti-infective properties of breast milk. J. Pediatr. 94:1-9.
Yamashita, K. and A. Kobata. 1974. Oligosaccharides of human milk. Isolation and characterization of a new trisaccharide 6’-galactosyllactose. Arch. Biochem. Biophys. 1:39-44.
Yanahira, S., T. Kobayashi, T. Suguri, M. Nakakoshi, S. Miura,H. Ishikawa and I. Nakajima. 1995. Formation of oligosaccharides from lactose by Bacillus circulansβ-galactosidase. Bio. Biotech Biochem 59:1021-1026.
Ziemer, C. J. and G. R. Gibson. 1998. Anoverviewof probiotics, prebiotics and synbiotics in the functional food concept: perspectives and future strategies. Int. Dairy J. 8:473-479.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9528-
dc.description.abstract本試驗之目的在研究比較小鼠的日常飲食中添加山羊乳寡醣或半乳寡醣對其腸道菌相組成及免疫能力的影響。試驗中所使用的山羊乳寡醣是利用快速液態層析儀分離再濃縮後所得。本試驗使用40隻4週齡大的雄性BALB/c小鼠為受試對象,總飼養期間為兩個月。四個試驗組分別為1)對照組;2)半乳寡醣組;3)酸性山羊乳寡醣組與4)中性山羊乳寡醣組。三個寡醣處理組餵飼劑量均為每日500 mg/每公斤體重。餵飼四週後,所有小鼠均進行遲發性過敏反應(delayed-type hypersensitivity)檢測。隨後,利用腹腔注射卵白蛋白來對小鼠進行特異性免疫反應測試,追蹤血漿中免疫球蛋白G(IgG) 及免疫球蛋白M (IgM) 的濃度變化。隨後,當飼養滿八週後,採集小鼠血液樣本進行特異性免疫反應測試及血液血球計數分析試驗。接著犧牲所有小鼠,解剖取得其腸道與脾臟。在腸道取1)結腸絨毛;2)結腸內容物;3)盲腸絨毛及4)盲腸內容物後再加上5)糞便,分別檢測其菌數。檢測的菌種為1)Bifidobacterium spp.;2)Lactobacillus spp.;3) Clostridium perfringens及4) Escherichia coli。而脾臟則用以進行淋巴細胞增生能力的測試。本試驗結果顯示,在遲發性過敏反應上,三個寡醣處理組都較對照組有較小的腫脹程度。血液血球計數分析的結果,則呈現三寡醣處理組在單位血液量中的白血球、淋巴球與單核球三種細胞數目皆高於對照組。特異性免疫反應方面,半乳寡醣組與酸性山羊乳寡醣組的小鼠血漿中IgG及IgM濃度亦顯著較對照組為高。淋巴細胞增生能力上,半乳寡醣組與酸性山羊乳寡醣組有較對照組強的T淋巴球增生表現。最後,腸道菌數檢測的結果,半乳寡醣組與酸性山羊乳寡醣組相較於對照組,顯著的提昇腸道中Bifidobacterium spp. 和 Lactobacillus spp. 的數目,並使E. coli下降,但在對照組與中性山羊乳寡醣組之間則較無差異。綜合上述結果,山羊乳寡醣在提昇小鼠免疫能力和增加腸道益菌數目上與半乳寡醣有類似的正面結果。zh_TW
dc.description.abstractThe purpose of this study was to investigate the effect of dietary supplementation of goat milk OS on intestinal bacterial composition and immunity of mice. The goat milk OS were isolated and concentrated by FPLC in NTU Animal Nutrition Lab. Forty male BALB/c mice of 4 weeks age were used in this study. They were randomly allocated to 4 treatments of 10 mice each treatment. The four treatments were: (1)control, (2)galacto-oligosaccharides(GOS), (3)acidic goat milk oligosaccharides(AOS) and (4)neutral goat milk oligosaccharides(NOS). After four weeks of OS feeding, all mice were subjected to the delayed-type hypersensitivity test. After eight weeks, blood samples were collected for assay of the blood cells numbers, immunoglobulin G, immunoglobulin M and splenic lymphocyte proliferation, and samples of the (1)colic content, (2)colic villus, (3)cecal content, (4)cecal villus and (5)feces were taken for culturing count of Bifidobacterium, Lactobacillus, Clostridium perfringens and Escherichia coli.
Results showed that all three OS treatments were higher in quantities of leukocytes, lymphocytes, and monocytes than the control group. In delayed-type hypersensitivity test, the swollen skin areas were smaller in the GOS, AOS, and NOS groups. Plasma IgG and IgM concentrations of mice in GOS or AOS group were significantly higher than those of control group. The lymphocyte proliferation competence in GOS and AOS groups was higher for T cell proliferation. In the intestinal bacterial composition, the number of Bifidobacterium spp. and Lactobacillus spp. increased significantly and E. coli decreased in the GOS and AOS groups, but there was not difference between NOS and control groups.
In conclusion, goat milk oligosaccharides have ameliorative effect on immunity and intestinal bacterial composition, which was similar to the effects of GOS.
en
dc.description.provenanceMade available in DSpace on 2021-05-20T20:27:02Z (GMT). No. of bitstreams: 1
ntu-97-R93626010-1.pdf: 888487 bytes, checksum: 349700702d02f1c90366db707c83700d (MD5)
Previous issue date: 2008
en
dc.description.tableofcontents目錄 ii
表次 iii
壹、緒言 1
貳、中文摘要 3
參、英文摘要 4
肆、文獻檢討 6
伍、材料與方法 32
陸、結果與討論 36
柒、結論 45
捌、參考文獻 46
附錄 64
dc.language.isozh-TW
dc.title山羊乳寡醣改善小鼠腸內細菌菌相與免疫調節功能之評估zh_TW
dc.titleEvaluation of modification capability of goat milk oligosaccharides on mouse intestinal bacterial composition and immunityen
dc.typeThesis
dc.date.schoolyear96-2
dc.description.degree碩士
dc.contributor.oralexamcommittee#VALUE!
dc.subject.keyword小鼠,山羊乳寡醣,免疫,腸內菌相,zh_TW
dc.subject.keywordmouse,goat milk oligosaccharides,immunity,intestinal bacterial composition,en
dc.relation.page68
dc.rights.note同意授權(全球公開)
dc.date.accepted2008-08-20
dc.contributor.author-college生物資源暨農學院zh_TW
dc.contributor.author-dept動物科學技術學研究所zh_TW
顯示於系所單位:動物科學技術學系

文件中的檔案:
檔案 大小格式 
ntu-97-1.pdf867.66 kBAdobe PDF檢視/開啟
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved